Central Blood Pressure and Pulse Wave Velocity in Kidney Transplant Recipients
Central Blood Pressure and Pulse Wave Velocity in Children With and Without Kidney Transplants
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The specific aims of the study are as follows:
- Using an oscillometric blood pressure monitor, the investigators aim to non-invasively obtain the central blood pressure and pulse wave velocity (PWV), or arterial stiffness, of children with kidney disease.
- Measure oscillometric central blood pressure and PWV in age and race matched healthy children.
- Measure PWV by standard arterial tonometry method in a subset of patients, and compare these measurements to the PWV measured using the oscillometric device.
- Measure body composition of patients and controls (Body Mass Index, Waist-to-Height ratio, %body fat, and mid-arm muscle circumference) to see how this relates to central blood pressure and PWV.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Kristen Sgambat, PhD
- Phone Number: 202-476-5058
- Email: ksgambat@childrensnational.org
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Children's National Medical Cetner
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- kidney transplant recipients who are at least 6 months post-transplant
- healthy children matched for age sex and race
Exclusion Criteria:
- age less than 3 years
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
children with kidney disease
Kidney transplant recipients age 3 to 21 years
|
There is no intervention in this study.
It is observational only.
|
|
healthy control
Healthy children age 3 to 21 years
|
There is no intervention in this study.
It is observational only.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oscillometric central blood pressure
Time Frame: cross-sectional measurement performed in patients who are between 6 months to 10 years post-transplant
|
Central blood pressure as measured by oscillometric blood pressure device
|
cross-sectional measurement performed in patients who are between 6 months to 10 years post-transplant
|
|
Oscillometric pulse wave velocity
Time Frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
Pulse wave velocity as measured by oscillometric blood pressure device
|
cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass index (BMI) in kg/m2
Time Frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
weight measured in kg and height measured in cm will be combined to determine BMI (kg/m2)
|
cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
|
Waist circumference (cm)
Time Frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
waist circumference will be measured in cm using a flexible tape measure
|
cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
|
Mid arm circumference (cm)
Time Frame: cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
Mid arm circumference will be measured in cm using a flexible tape measure
|
cross-sectional measurement performed in patients who are anywhere between 6 months to 10 years post-transplant
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00013491
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.